Tim Casey

Executive Editor




LATEST ARTICLES BY THIS AUTHOR

Most FDA-approved high-risk cardiovascular device studies are published in peer-reviewed literature
As FDA commissioner, Califf plans on focusing on evidence-based medicine
ACC releases lifelong learning competencies document for cardiologists
Physicians preach caution when interpreting and implementing SPRINT trial results
Boston Scientific chairman and co-founder to retire in May; CEO will replace him
Senate confirms Califf as FDA commissioner
FDA approves Boston Scientific’s quadripolar leads
Death rates associated with in-hospital cardiogenic shock following acute MI decline in recent years
FDA rejects expanded indications for Merck cholesterol drugs
High-dose tirofiban during PCI is associated with significant reduction in all-cause mortality